Mosby’s Nursing Consult Now Available on the App Store
Patient education, drug information and morePhiladelphia, PA, April 17, 2013
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of its Mosby’s Nursing Consult App, now on the App Store for iPhone, iPad and iPod touch. Mosby’s Nursing Consult puts trusted clinical information into nurses’ hands.
- Patient education (including Spanish when available)
- Drug calculators
- Drug monograph sections
- Nursing recommendations from evidence-based nursing monographs
“The Mosby’s Nursing Consult App makes drug information, patient handouts, and evidence-based nursing recommendations available at the point of care,” said Cindy Tryniszewski, RN, MSN, Executive Director, Clinical E-Learning, Elsevier. “Nurses will be able to find clinical answers more quickly so they can spend more time on patient care.”
Updated patient handouts, drug monographs and evidence-based nursing monographs from Nursing Consult are available every time a nurse accesses the app and is connected to the Internet, while the drug calculators will work online or offline. Being able to access Nursing Consult through an app means that nurses can get the clinical information they need anywhere, any time, wherever their patients are located.
Mosby's Nursing Consult is the most trusted and comprehensive online resource for nurses, offering authoritative information to help provide better patient care.
The Mosby’s Nursing Consult App is available for free from the App Store on iPhone, iPad and iPod touch or at www.AppStore.com.
For additional information on Mosby’s Nursing Consult App, go to http://confidenceconnected.com or call +1 866 416 6697.
# # #About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Corporate Relations
+1 212 633 3164